Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole- resistant and -sensitive strains

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2602-2605

  Matsumoto, Satoru ^a   Washizuka, Yukari ^a   Matsumoto, Yoshimi ^a   Tawara, Shuichi ^a   Ikeda, Fumiaki ^a   Yokota, Yoshiko ^a   Karita, Mikio ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b Hofu Onsen Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACITRACIN; METRONIDAZOLE; NALIDIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; HELICOBACTER PYLORI; INOCULATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0030734123     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2602     Document Type: Article

References (32)

1. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, A. Roda, and E. Roda. 1993. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Gastroenterology 104:A40.
2. Becx, M. C. J. M., A. J. H. M. Janssen, H. A. L. Claaener, and R. W. de Koning. 1990. Metronidazole-resistant Helicobacter pylori. Lancet 335:539-540.
3. Bell, G. D., C. M. Bate, A. T. R. Axon, G. Tildesley, G. D. Kerr, J. R. B. Green, C. E. Emmas, and M. D. Taylor. 1995. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment. Pharmacol. Ther. 9:513-520.
4. Blaser, M. J., and J. Parsonnet. 1994. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest. 94:4-8.
5. Borody, T. J., P. Cole, S. Noonan, A. Morgan, J. Lenne, L. Hyland, S. Brandl, E. G. Borody, and L. L. George. 1989. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med. J. Aust. 151:431-435.
6. Edwards, D. I. 1993. Nitroimidazole drugs - action and resistance mechanisms. 1. Mechanisms of resistance. J. Antimicrob. Chemother. 31:9-20.
7. Edwards, D. I. 1993. Nitroimidazole drugs - action and resistance mechanisms. 2. Mechanisms of resistance. J. Antimicrob. Chemother. 31:201-210.
8. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. 1992. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11:777-781.
9. Glupczynski, Y., A. Burette, E. De Koster, J. F. Nyst, M. Deltenre, S. Cadranel, L. Bourdeaux, and D. De Vos. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977.
10. Goddard, A. F., and R. P. H. Logan. 1996. Antimicrobial resistance and Helicobacter pylori. J. Antimicrob. Chemother. 37:639-643.
11. Goodwin, C. S., B. J. Marshall, E. D. Blincow, D. H. Wilson, S. Blackbourn, and M. Phillips. 1988. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth sucitrate: clinical and in vitro studies. J. Clin. Pathol. 41:207-210.
12. Graham, D. Y. 1989. Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615-625.
13. Graham, D. Y. 1995. A reliable cure for Helicobacter pylori infection? Gut 37:154-156.
14. Graham, D. Y., W. A. de Boer, and G. N. J. Tytgat. 1996. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am. J. Gastroenterol. 91:1072-1076.
15. Haas, C. E., D. E. Nix, and J. J. Schentag. 1990. In vitro selection of resistant Helicobacter pylori. Antimicrob. Agents Chemother. 34:1637-1641.
16. Hirayama, F., S. Takagi, H. Kusuhara, E. Iwao, Y. Yokoyama, and Y. Ikeda. 1996. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J. Gastroenterol. 31:755-757.
17. Johnson, P. J. 1993. Metronidazole and drug resistance. Parasitol. Today 9:183-186.
18. Karita, M., T. Kouchiyama, K. Okita, and T. Nakazawa. 1991. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am. J. Gastroenterol. 86:1596-1603.
19. Karita, M., Q. Li, D. Cantero, and K. Okita. 1994. Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am. J. Gastroenterol. 89:208-213.
20. Karita, M., Q. Li, and K. Okita. 1993. Evaluation of new therapy for eradication of H. pylori infection in nude mouse model. Am. J. Gastroenterol. 88:1366-1372.
21. Krakowka, S., D. R. Morgan, W. Kraft, and R. D. Leunk. 1987. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect. Immun. 55:2789-2796.
22. Logan, R. P. H., P. A. Gummett, J. J. Misiewicz, Q. N. Karim, and M. M. Walker. 1991. One week eradication regimen for Helicobacter pylori. Lancet 338:1249-1252.
23. Marchetti, M., B. Arico, D. Burroni, N. Figura, R. Rappuoli, and P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267:1655-1658.
24. Matsumoto, S., Y. Washizuka, Y. Matsumoto, S. Tawara, F. Ikeda, Y. Yokota, and M. Karita. 1997. Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. J. Med. Microbiol. 46:391-397.
25. Matsumoto, S., Y. Washizuka, Y. Matsumoto, S. Tawara, and M. Karira. 1995. The role of motility in colonization of the euthymic mice gastric mucosa with H. pylori, abstr. 15, p. 33. In The First Meeting of the Japanese Research Society for Helicobacter pylori Related Gastroduodenal Diseases. The Japanese Research Society for Helicobacter pylori Related Gastroduodenal Diseases, Tokyo, Japan.
26. Meingassner, J. G., and J. Thurner. 1979. Strain of Trichomonas vaginalis resistant to metronidzole and other 5-nitroimidazoles. Antimicrob. Agents Chemother. 15:254-257.
27. NIH Consensus Conference. 1994. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69.
28. O'Riordan, T., E. Mathai, E. Tobin, D. McKenna, C. Keane, E. Sweeney, and C. O'Morain. 1990. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31:999-1002.
29. Rautelin, H., K. Swppala, O. V. Renkonen, U. Vainio, and T. U. Kosunen. 1992. Role of metronidazole resistance in therapy of Helicobacter pylori infection. Antimicrob. Agents Chemother. 36:163-166.
30. Shuto, R., T. Fujioka, T. Kubota, and M. Nasu. 1993. Experimental gastritis induced by Helicobacter pylori in Japanese monkeys. Infect. Immun. 61:933-939.
31. Tytgat, G. N. J. 1995. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease. Aliment. Pharmacol. Therap. 9:39-42.
32. van Zwet, A. A., J. C. Thijs, W. Schievink de Vries, and J. Schiphuis. 1994. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 38:360-362.